https://www.icandecide.org/ican_foia/nih-officials-stand-to-earn-millions-from-moderna-vaccine/
ICAN can now officially confirm that officials within the National Institute of Health (NIH) who are working to develop a vaccine for novel coronavirus (COVID-19) stand to personally earn millions of dollars from sales of this vaccine.
When government officials will profit from the sale of a product, there is cause for concern regarding their licensure and promotion of that product.
The first vaccine for COVID-19 to begin trials in the United States is mRNA-1273. This experimental vaccine was developed by Dr. Anthony Fauci’s National Institute of Allergy and Infectious Disease (NIAID), which is part of the NIH, along with a biotech company, Moderna Inc., the company that will sell this product to the public.
To receive a share of the profit from the sale of mRNA-1273, the inventors of this product within NIAID would submit an Employee Invention Report to the NIH Office of Technology Transfer. Each inventor stands to receive a personal payment of up to $150k annually from the sales of mRNA-1273. NIAID also stands to earn millions of dollars in revenue from the sale of mRNA-1273 in addition to what its inventors within NIAID earn personally.
Moderna will pay a license fee to NIAID (or its parent agency) to use its patents related to mRNA-1273 and a portion of those fees are then paid directly to the inventors within NIAID who developed those patents.
There are two patents for which the following six individuals in NIAID appear to be listed as inventors which relate to development of mRNA-1273:
Barney Graham, Deputy Director, NIAID Vaccine Research Center
Kizzmekia Shanta Corbett, Scientific Lead, NIAID’s Coronavirus Vaccine Program
Michael Gordon Joyce, NIAID
Hadi Yassine, NIAID
Masaru Kanekiyo, NIAID
Olubukola Abiona, NIAID